Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Fintech Innovation ETF (ARKF) vs Intuitive Surgical, Inc. (ISRG) Price & Performance

ARK Fintech Innovation ETFTrade
Intuitive Surgical, Inc.Trade

Price performance (Past 24H)

Key statistics

ARK Fintech Innovation ETF vs Intuitive Surgical, Inc. — how do they compare? ARK Fintech Innovation ETF trades at $42.7, while Intuitive Surgical, Inc. trades at $402.15 (market cap $141.75B). Which is the better fit depends on your goals.

ARKFISRG
Sector
Sector/ThematicHealth
52-Week High
$58.82$592.85
52-Week Low
$36.14$332.02
Market Cap
$141.75B
Enterprise Value
$136.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Fintech Innovation ETF

ARKF trades at $42.70, down 0.93% today amid a broader fintech and crypto sector consolidation. The ETF's technical outlook is bullish based on moving averages, but oscillators are neutral with an overbought short-term RSI. Recent underperformance includes a 23% decline since July 2025, lagging the S&P 500 by 45 percentage points, with elevated volatility at 33.6%.

Outlook remains cautious due to high valuation multiples and sector headwinds. Risks include stretched P/E of 33x and PEG of 2.0x, signaling potential overvaluation. Investor sentiment is mixed, with a Hold rating reflecting fair valuation concerns amid ongoing consolidation pressures.

Intuitive Surgical, Inc.

Intuitive Surgical (ISRG) trades at $403.95, up 2.69% on the day, reflecting strong momentum. The stock exhibits bullish technical signals with support at $398 and resistance at $403. Fundamentally, revenue grew to $10.06B in 2025 with a net income margin of 28.45%, though valuation ratios like a P/E of 46.01 suggest premium pricing. Recent quarters show consistent earnings beats, with Q2 2026 EPS of $2.80 exceeding expectations. News highlights analyst upgrades and robust adoption of the da Vinci 5 system.

Outlook remains positive driven by innovation and market expansion, but high valuation and competitive pressures pose risks. The consensus price target of $518.10 implies significant upside, supported by 68% buy ratings from analysts. Key risks include reliance on U.S. procedure growth and rising competition from Medtronic and Johnson & Johnson. Long-term growth prospects appear solid if execution continues.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ARK Fintech Innovation ETF

ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.

Read more on ARKF

About Intuitive Surgical, Inc.

Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.

Read more on ISRG